Aviva PLC Director/PDMR Shareholding (7800G)

TIDMAV.

RNS Number : 7800G

Aviva PLC

08 November 2018

8 November 2018

AVIVA PLC ("Aviva")

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs")

Aviva announces that:

Andrew Briggs, Chief Executive Officer UK Insurance, purchased 25,000 ordinary shares on 7 November 2018 at a price of GBP4.23. Full details of the share purchase are set out below.

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

Media Enquiries:

   Andrew Reid                                                                  [phone] 

General Enquiries:

   Roy Tooley, Company Secretarial                                    [phone] 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them

 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
 a)    Name                                   ANDREW BRIGGS 
      -------------------------------------  -------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------- 
 a)    Position/status                        CHIEF EXECUTIVE OFFICER UK INSURANCE 
      -------------------------------------  -------------------------------------------- 
 b)    Initial notification/Amendment         INITIAL NOTIFICATION 
      -------------------------------------  -------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------- 
 a)    Name                                   AVIVA PLC 
      -------------------------------------  -------------------------------------------- 
 b)    LEI                                    YF0Y5B0IB8SM0ZFG9G81 
      -------------------------------------  -------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      ----------------------------------------------------------------------------------- 
 a)    Description of the financial 
        instrument, type of instrument                     *    SHARES 
        Identification code 
 
 
                                                           *    GB0002162385 
      -------------------------------------  -------------------------------------------- 
 b)    Nature of transaction                  PURCHASE OF 25,000 AVIVA PLC ORDINARY 
                                               SHARES 
      -------------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s)                 Price(s)                          Volume(s) 
      -------------------------------------  --------------------------------  ---------- 
   GBP4.23                                                                      25,000 
  ---------------------------------------------------------------------------  ---------- 
                  Aggregated information 
                    *    Aggregated volume       *    GBP4.23 per share 
 
 
 d)                 *    Price                   *    Total Price GBP105,750     25,000 
      -------------------------------------  --------------------------------  ---------- 
 e)    Date of the transaction                2018-11-07 
      -------------------------------------  -------------------------------------------- 
 f)    Place of the transaction               LONDON STOCK EXCHANGE, XLON 
      -------------------------------------  -------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBVLFBVFFXFBB

(END) Dow Jones Newswires

November 08, 2018 05:32 ET (10:32 GMT)